StockData
Immatics N.V. logo

Immatics N.V. (IMTX) shareholders

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
74.4%
100M of 134M shares
Institutional holders
83
12 new, 13 sold out
Net institutional buying
-8M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $7.50M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
T. Rowe Price Investment Management, Inc.21,652,16216.10%13G (passive) amendmentMar 31, 2026
Roderick Wong
Joint filing with RTW Investments, LP (9.60%)
12,869,3409.60%13G (passive) amendmentMar 31, 2026
Joseph Edelman
Joint filing with Perceptive Advisors LLC (7.60%), Perceptive Life Sciences Master Fund, Ltd. (7.60%)
11,418,0167.60%13D (active) amendmentAug 26, 2026
Aaron Cowen
Joint filing with Suvretta Capital Management, LLC (8.30%), Averill Master Fund, Ltd (7.10%)
11,190,1298.30%13G (passive) amendmentDec 31, 2025
Baker Bros. Advisors LP
Joint filing with Baker Bros. Advisors (GP) LLC (8.40%), Julian C. Baker (8.40%) and 1 more
10,168,9018.40%13G (passive) amendmentJun 30, 2025
Felix J. Baker
Joint filing with Baker Bros. Advisors LP (7.00%), Baker Bros. Advisors (GP) LLC (7.00%) and 1 more
9,508,5657.00%13G (passive) amendmentJun 30, 2026
Suvretta Capital Management, LLC
Joint filing with Aaron Cowen (7.50%), Averill Master Fund, Ltd. (6.70%)
9,135,0297.50%13G (passive) amendmentMar 31, 2025
RTW Investments, LP
Joint filing with Roderick Wong (7.30%)
8,815,6177.30%13G (passive) amendmentSep 30, 2025
Wellington Group Holdings LLP
Joint filing with Wellington Management Group LLP (7.10%), Wellington Investment Advisors Holdings LLP (7.10%) and 1 more
8,583,5687.10%13G (passive) amendmentMar 31, 2025
The Toronto-Dominion Bank7,436,3425.50%13G (passive)Mar 31, 2026
Baker Bros. Advisors (GP) LLC
Joint filing with Baker Bros. Advisors LP (6.00%), Julian C. Baker (6.00%) and 1 more
7,275,8306.00%13G (passive) amendmentDec 31, 2024
Roderick Wong, M.D.
Joint filing with RTW Investments, LP (5.50%)
6,540,5405.50%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of IMTXValueChange% of portfolio
T. Rowe Price Investment Management, Inc.22,365,04616.68%$226.56M+712,8840.15%
Rtw Investments, LP12,946,1769.66%$131.14M+76,8361.12%
Suvretta Capital Management, LLC11,190,1298.35%$113.36M–2.07%
Perceptive Advisors LLC10,383,4567.74%$105.18M–1.58%
Baker Bros. Advisors LP9,508,5657.09%$96.32M−1,408,1280.48%
Jefferies Financial Group Inc.6,506,8024.85%$65.91M+1,447,2510.43%
Vestal Point Capital, LP6,175,0004.61%$62.55M–1.46%
Sofinnova Investments, Inc.3,669,3462.74%$37.17M+38,8921.92%
Morgan Stanley2,186,4941.63%$22.15M+37,4120.00%
Citadel Advisors LLC1,814,6571.35%$18.38M−37,3060.00%
Wellington Management Group Llp1,647,8521.23%$16.69M+85,9600.00%
Point72 Asset Management, L.P.1,449,5971.08%$14.68M−44,2030.02%
Woodline Partners LP900,7360.67%$9.12M−99,8610.03%
Sphera Funds Management Ltd.720,0570.54%$7.29M+23,9520.95%
University Of Texas/Texas Am Investment Managment Co697,4310.52%$7.06M–0.82%
abrdn plc653,6040.49%$6.62M−167,1130.01%
Qube Research & Technologies Ltd523,2170.39%$5.30M+156,4450.00%
Boxer Capital Management, LLC475,0000.35%$4.81MNew0.36%
TD Asset Management Inc449,3480.34%$4.55M−21,0960.00%
Wasatch Advisors LP441,5100.33%$4.47M−23,3130.03%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202683100M74.4%12 / 2533 / 134M12M
Q1 202684108M80.7%15 / 2724 / 612M10M
Q4 202575106M79.4%19 / 2721 / 724M10M
Q3 20256393M69.0%9 / 1721 / 1611M11M
Q2 20257093M69.4%17 / 2417 / 2316M14M
Q1 20257691M68.1%15 / 2421 / 2416M17M
Q4 20248592M68.8%17 / 3424 / 2326M10M
Q3 20249176M56.8%16 / 1742 / 137M7M
Q2 20249078M58.0%23 / 3026 / 1014M10M
Q1 20247773M54.6%18 / 2923 / 1728M8M
Q4 20237652M39.1%13 / 3420 / 1112M4M
Q3 20237445M33.5%11 / 3218 / 57M3M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Jasuja Harpreet SinghChief Executive Officer, Director217,2410.16%Mar 18, 2026
James Nelson PepinGen Counsel and Corp Secretary––Aug 18, 2026
Jordan Zeik SilversteinHead of Strategy7,8260.01%Mar 18, 2026
Cedrik Michael BrittenChief Medical Officer2500.00%Mar 18, 2026
Amie Elizabeth KrauseChief People Officer––Mar 18, 2026
Carsten Alexander Johannes ReinhardtChief Development Officer47,7810.04%Mar 18, 2026
Steffen Martin WalterChief Operating Officer10,0000.01%Mar 18, 2026
Venkat RamananChief Financial Officer––Mar 18, 2026
Rainer KramerChief Business Officer––Mar 18, 2026
Toni Michael WeinschenkChief Innovation Officer––Mar 18, 2026
Edward A. Sturchio JrGeneral Counsel––Mar 18, 2026
Advisors Llc PerceptiveDirector––Aug 27, 2026
Joseph EdelmanDirector11,246,5168.39%Aug 27, 2026
Life Sciences Master Fund Ltd PerceptiveDirector––Aug 27, 2026
Alise ReicinDirector––Jun 18, 2026
Eliot ForsterDirector––Jun 18, 2026
Michael G. AtiehDirector––Jun 18, 2026
Heather L. MasonDirector––Jun 18, 2026
Paul Rutherford CarterDirector––Jun 18, 2026
Peter Alan ChambreDirector105,9870.08%Jun 18, 2026
Mathias HothumDirector329,5210.25%Jun 18, 2026
Adam Leo StoneDirector––Jun 18, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Joseph Edelman
Director
Aug 26, 2026Buy+863,060$8.69$7.50M11,246,516

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
4M shares short
Days to cover
3.0
At 1M shares a day
Change since last report
-2.1%
From 4M shares
Short volume, 20 days
32.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Immatics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 259,564 shares on Aug 28, 2026 over the last 90 days.

See a number that looks wrong?